NASDAQ:KRON
Kronos Bio, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
kronosbio.comipo date
Oct 09, 2020
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally administered, selective spleen t...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus